The global preclinical CRO market was valued at USD 6.4 billion in 2024. IMARC Group projects the market to grow at a CAGR of 6.5% from 2025 to 2033, reaching USD 11.3 billion by 2033. This growth is driven by increased pharmaceutical R&D activities and rising demand for cost-efficient preclinical testing services. https://www.imarcgroup.com/preclinical-cro-market